skip to main content

Questions and Answers Regarding Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus: Guidance for Industry

U.S. Food and Drug Administration. (2016). Questions and Answers Regarding Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus: Guidance for Industry.

The U.S. Food and Drug Administration released this guidance in response to questions from blood establishments asked regarding the original recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus.
Please Login to Add favorite.
This Article is not Rated. 0-5 Stars Please Login to rate.
You must login to add a comment.